Kira Pharmaceuticals names new COO and CFO
17 November 2021 -

Kira Pharmaceuticals, a US-based global biotechnology company, announced on Tuesday that it has named Teri Loxam as its new chief operating officer and chief financial officer.

Loxam is to replace interim CFO Matt Gorman and will manage finance along with several strategic and operational functions for the company.

Loxam has served as CFO of SQZ Biotechnologies, senior vice president of Investor Relations and Global Communications at Merck, vice president of Investor Relations at IMAX and held senior strategic roles at Bristol-Myers Squibb. Presently, she serves on the board of Vaxcyte and as an advisor to Cardiol Therapeutics.